NANOBIOTIX reports a Return on Equity (ROE) of 28.36%.

What is NBTX's dividend yield?

NANOBIOTIX offers a dividend yield of 0.00%.

What is NBTX's Quality Score?

Our AI rates NBTX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NBTX?

Our AI Timing Score for NBTX is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NBTX belong to?

NANOBIOTIX is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

NBTX (NASDAQ) Stock Analysis | NANOBIOTIX

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2025-12-31)

NBTX AI Analysis Summary

Our AI summary for NBTX: NANOBIOTIX (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 28.36%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NBTX

NANOBIOTIX

US:NASDAQ STOCK Healthcare >> Biotechnology News 79

USD 38.39

-1.77 (-4.41%) Day Change

Watchlist Portfolio Compare Chart

-1.11

D/E

28.4%

ROE

-35.4%

ROA

0.00%

Div Yield

NANOBIOTIX
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 38.39 Price -1.77 (-4.41%) Day Change	NEWS SCORE: 79

NBTX, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	79
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	38.39
PBV / Sector	-21.73 / 5.20
Earning Per Share	-0.50

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	5.04 M GREAT
Average 1W Daily Value	5.28 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

50%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-80.83 / 98.71
NPM Average (%) / Sector	-109.30 / -1,721.76
NPM Change Average (%) / Sector	-387.86 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-35.36 / 27.02
ROA Average (%) / Sector	-68.53 / -368.17
ROA Change Average (%) / Sector	6.10 / 5,404.12
ROE (%) / Sector	28.36 / 3.47 GOOD
ROE Average (%) / Sector	623.97 / 6.51 GREAT
ROE Change Average (%) / Sector	250.98 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:13
Symbol	NBTX
Name	NANOBIOTIX
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	50.79 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	1,835.56 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 60 rue de Wattignies, Paris, France, 75012

Phone: 33 1 40 26 04 70

Website: https://www.nanobiotix.com

Employees: 100

Sector: Healthcare >> Biotechnology

Description: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.